Merck & Co Inc (MRK)

Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell

$76.90

Buy

$77.35

arrow-down$-0.10 (-0.13%)

Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.
Prices updated at 31 May 2025, 00:57 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-down-0.01%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Drug Manufacturers - General
Chairman
Mr. Robert M. Davis
CEO
Mr. Robert M. Davis
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
75,000
Head office
126 East Lincoln Avenue
Rahway
United States
07065
mobile
+1 908 740-4000
letter
investor_relations@merck.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Douglas M. Baker, Jr
Independent Director
0.13m--0.35m-
Mr. Inge G. Thulin
Independent Director
0.12m--0.34m-
Mr. Richard R. DeLuca, Jr
Executive Vice President and President, Merck Animal Health
0.96m--9.10m-
Ms. Patricia F. Russo
Independent Director
0.14m--0.36m-
Mr. Robert M. Davis
Chairman of the Board, President and Chief Executive Officer
1.62m--23.19m-
Mr. Thomas Henry Glocer
Lead Independent Director
0.19m--0.44m-
Ms. Pamela J. Craig
Independent Director
0.15m--0.40m-
Dr. Risa J. Lavizzo-Mourey,M.D.
Independent Director
0.12m--0.36m-
Ms. Kathy J. Warden
Independent Director
0.13m--0.35m-
Dr. Paul B. Rothman, M.D.
Independent Director
0.15m--0.41m-
Ms. Betty D. Larson
Executive Vice President and Chief Human Resources Officer
0.60m0.73m-11.26m-
Mr. Sanat Chattopadhyay
Executive Vice President and President, Merck Manufacturing
-----
Ms. Mary Ellen Coe
Independent Director
0.12m--0.34m-
Mr. Chirfi Guindo
Senior Vice President, Human Health and Chief Marketing Officer
-----
Ms. Jennifer Zachary
Executive Vice President and General Counsel
-----
Ms. Caroline A. Litchfield
Executive Vice President and Chief Financial Officer
1.17m--7.51m-
Dr. Christine E. Seidman, M.D.
Independent Director
0.13m--0.38m-
Mr. David Michael Williams
Executive Vice President and Chief Information and Digital Officer
-----
Dr. Stephen L. Mayo, PhD
Independent Director
0.13m--0.35m-
Mr. Dean Y. Li, M.D.,PhD
Executive Vice President and President, Merck Research Laboratories
1.45m--10.09m-
Mr. Michael A Klobuchar
Executive Vice President and Chief Strategy Officer
-----
Ms. Cristal N. Downing
Executive Vice President and Chief Communications and Public Affairs Officer
-----
Mr. Jannie Oosthuizen
Senior Vice President and President, Merck U.S. Human Health
-----
Mr. Joseph Romanelli
Senior Vice President and President, MSD, International Human Health
-----
Mr. Dalton E. Smart, III
Senior Vice President, Finance, Global Controller and Principal Accounting Officer
-----
Mr. Surendralal L. Karsanbhai
Independent Director
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc252,513,3810.4097814172740.56443530 Apr 202510.06
BlackRock Inc225,398,2310.4249533163861.49331730 Apr 20258.98
State Street Corp120,529,6400.44979-379666-0.31400930 Apr 20254.80
BlackRock Fund Advisors89,596,97753.77929-8719222-30 Apr 20253.57
Wellington Management Company LLP81,669,6511.410119276211.1488730 Apr 20253.25

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
30 Sep 2024-Mr. Thomas Henry Glocer113.5648,71797,075--
30 Sep 2024-Ms. Mary Ellen Coe113.5629,98023,574--
30 Sep 2024-Dr. Christine E. Seidman, M.D.113.568,06314,977--
05 Aug 2024-Mr. Chirfi Guindo115.202,005,86240,370--
05 Aug 2024-Mr. Chirfi Guindo--36,903--
05 Aug 2024-Mr. Chirfi Guindo115.204,250,99557,782--
28 Jun 2024-Mr. Thomas Henry Glocer123.8048,65396,063--
28 Jun 2024-Ms. Mary Ellen Coe123.8029,96023,170--
28 Jun 2024-Dr. Christine E. Seidman, M.D.123.808,04714,816--
31 May 2024-Mr. Douglas M. Baker, Jr125.54219,9466,282--
31 May 2024-Mr. Inge G. Thulin125.54219,94621,229--
31 May 2024-Ms. Patricia F. Russo125.54219,94653,952--
31 May 2024-Mr. Thomas Henry Glocer125.54219,94695,669--
31 May 2024-Ms. Pamela J. Craig125.54219,94628,234--
31 May 2024-Dr. Risa J. Lavizzo-Mourey,M.D.125.54219,94612,120--
31 May 2024-Ms. Kathy J. Warden125.54219,94612,253--
31 May 2024-Dr. Paul B. Rothman, M.D.125.54219,94628,234--
31 May 2024-Ms. Mary Ellen Coe125.54219,94622,927--
31 May 2024-Dr. Christine E. Seidman, M.D.125.54219,94614,750--
31 May 2024-Dr. Stephen L. Mayo, PhD125.54219,9469,380--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.